Skip to main content
. Author manuscript; available in PMC: 2010 Apr 22.
Published in final edited form as: Pharmacol Biochem Behav. 2008 Aug 23;91(2):261–270. doi: 10.1016/j.pbb.2008.08.018

Fig. 2.

Fig. 2

Mean (±SEM) levels of 3α,5α-THP in midbrain (F1,44=77.35; top left), hippocampus (F1,44=20.52; top right), striatum (F1,44=14.42; bottom left), and cortex (F1,44=4.28; bottom right) of ovariectomized vehicle- (gray) or E2-primed (black) rats infused with β-cyclodextrin vehicle (striped bars) or 3α,5α-THP (solid bars) to the VTA. * indicates 3α,5α-THP-infused rats had significantly higher levels of 3α,5α-THP than did vehicle–vehicle controls (P<0.05). ** indicates E2-primed rats infused with 3α,5α-THP had significantly higher 3α,5α-THP levels than did vehicle-primed rats infused with 3α,5α-THP (F1,44=6.72, P<0.05). # indicates tendency for E2-primed rats to have higher levels of 3α,5α-THP than vehicle-primed rats (F1,44=3.42, P<0.10).